TD Cowen projects that with Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) continuing their dominance, global sales of the GLP-1 class of weight loss/obesity drugs could reach $139B by 2030, indicating ...

CompanyOverview|NASDAQ:GILD] Gilead Sciences Inc. (NASDAQ: GILD) stock surged to a new 52-week high at $106.69 recently on ...

Our fair value estimate for Inghams is AUD 3.70 per share. This implies a fiscal 2024 enterprise value/EBITDA of 4, a P/E ratio of 12, and fully franked dividend yield of 6%. Our DCF valuation assumes ...

The new internal AI tool helps Walmart’s merchandising team analyze sales, pricing, and inventory faster than ever.

Automotive Adaptive Front Lighting Industry Increasing demand for autonomous and semi-autonomous vehicles technological advancements in aut ...

Shares of Australia's Telix Pharmaceuticals jumped to a record high on Friday after the company forecast bumper revenue for the current year and logged a nine-fold jump in 2024 profit, driven by sales ...

CEO Jack Sinclair highlighted the company's strong performance in 2024, with a 13% increase in total sales and a bottom-line margin improvement of over 70 basis points. He emphasized the focus on the ...

Sprouts Farmers Market delivered strong fourth-quarter earnings that surpassed expectations, bolstered by robust sales growth and strategic expansion efforts.

Stocks tumbled from all-time highs Thursday in the wake of Walmart projecting a lower-than-expected sales outlook. The Dow ...

Walmart's guidance for fiscal 2026 falls short of Wall Street expectations amid consumer spending concerns. Adjusted EPS forecasts are in the range of $2.50 to $2.60 versus an expected $2.76. Annual ...

Walmart on Thursday forecast sales and profit for the current year below Wall Street estimates, citing the need for caution ...

Baxter International exceeded Q4 earnings and revenue estimates, with strong pharmaceutical sales. The company issued a mixed 2025 outlook amid cost pressures.